US6372461B1 - Synthesis of vanillin from a carbon source - Google Patents

Synthesis of vanillin from a carbon source Download PDF

Info

Publication number
US6372461B1
US6372461B1 US09/397,720 US39772099A US6372461B1 US 6372461 B1 US6372461 B1 US 6372461B1 US 39772099 A US39772099 A US 39772099A US 6372461 B1 US6372461 B1 US 6372461B1
Authority
US
United States
Prior art keywords
vanillin
microbe
carbon source
acid
vanillic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US09/397,720
Other languages
English (en)
Inventor
John W. Frost
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Michigan State University MSU
Original Assignee
Michigan State University MSU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michigan State University MSU filed Critical Michigan State University MSU
Priority to US09/397,720 priority Critical patent/US6372461B1/en
Assigned to BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY reassignment BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FROST, JOHN W.
Application granted granted Critical
Publication of US6372461B1 publication Critical patent/US6372461B1/en
Assigned to NATIONAL SCIENCE FOUNDATION reassignment NATIONAL SCIENCE FOUNDATION CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS). Assignors: MICHIGAN STATE UNIVERSITY
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)

Definitions

  • the present invention is related to the bioconversion of a carbon source to vanillin and more particularly, to methods of producing vanillin from a carbon source by microbe-catalyzed conversion of the carbon source to vanillic acid and enzyme-catalyzed reduction of vanillic acid to produce vanillin.
  • Natural vanillin is produced from glucovanillin (FIG. 1) when the beans of the orchid Vanilla planifolia are submitted to a multi-step curing process.
  • natural vanillin can supply only 2 ⁇ 10 4 kg/yr of the world's 1.2 ⁇ 10 7 kg/yr demand for vanillin. Clark, G. S., Perfum. Flavor . 15:45 (1990).
  • Vanillin is second only to aspartame in terms of market size for a food additive.
  • Vanilla extract derived from V. planifolia pods has the advantage of being labeled as a natural flavoring.
  • only relative small volumes of vanilla flavoring can be derived from V. planifolia cultivation.
  • Synthesis of vanillin from benzene-derived guaiacol is therefore the basis of large-scale industrial manufacture of vanillin. This vanillin however, can not be labeled as a natural flavoring and synthesis of vanillin from benzene-derived guaiacol is not environmentally benign.
  • the microbes and cultured plant cells used to process the ferulic acid give low titers of vanillin (approximately 1 g/L).
  • the bioconversion methods of the present invention comprise the steps of microbe-catalyzed conversion of a carbon source to vanillic acid followed by enzyme-catalyzed reduction of vanillic acid to produce vanillin.
  • the microbe-catalyzed conversion step of the present invention requires five enzymes which are provided by a recombinant microbe.
  • the recombinant microbe is Escherichia coli designed to cause dehydration of 3-dehydroshikimic acid and regioselective methylation of the resulting protocatechuic acid.
  • the enzyme-catalyzed reduction step of the present invention comprises the reduction of vanillic acid to vanillin by aryl-aldehyde dehydrogenase.
  • the aryl-aldehyde dehydrogenase is purified from Neurospora crassa.
  • the biocatalytic synthesis of vanillin provided herein is environmentally benign, economically attractive, and utilizes abundant renewable sources, as starting materials.
  • FIG. 1 is a schematic illustrating various synthesis schemes for producing vanillin
  • FIG. 2 is a schematic illustrating the synthesis scheme of the present invention
  • FIG. 3 is a graph showing the effect over time of extracellular accumulation of various constituents on cells (g/L) and vanillate (mM);
  • FIG. 4 is a 1 H NMR of vanillin synthesized from glucose.
  • a bioengineered synthesis scheme for the production of vanillin from a carbon source is provided herein.
  • Methods of producing vanillin from a carbon source based on the synthesis scheme are also provided.
  • a method is provided wherein the carbon source is converted to vanillic acid by a recombinant microbe followed by the reduction of vanillic acid to vanillin by aryl-aldehyde dehydrogenase.
  • the aryl-aldehyde dehydrogenase is isolated from Neurospora crassa.
  • a single recombinant microbe may is employed to convert a carbon source to vanillic acid as well as reduce the vanillic acid to vanillin, e.g., the vanillic acid-synthesizing microbe may also express aryl-aldehyde dehydrogenase.
  • This “single-microbe conversion” may be carried out by any type of microbe sufficiently engineered to produce the desired outcome, including, but not limited to, E. coli , Klebsiella, Neurospora, Nocardia and Saccharomyces.
  • vanillic acid synthesized from a carbon source by one microbe is reduced to vanillin by a second microbe, wherein the second microbe expresses aryl-aldehyde dehydrogenase.
  • This “double-microbe conversion” may also be carried out by various types of microbes sufficiently engineered to produce the desired outcome. Neurospora and Nocardia are preferred as the second microbe, as both are known to naturally express aryl-aldehyde dehydrogenase.
  • the microbe-catalyzed conversion of the carbon source is to 3-dehydroshikimic acid followed by conversion of the 3-dehydroshikimic acid to vanillin.
  • the microbe-catalyzed conversion of the carbon source is to protocatechuic acid, followed by conversion of the protocatechuic acid to vanillin.
  • the conversion of 3-dehydroshikimic acid and/or protocatechuic acid to vanillin may be carried out by a second recombinant microbe engineered to provide such a conversion.
  • the bioconversion methods of the present invention are carried out under conditions of time, temperature, pH, nutrient type and concentration, aeration conditions, methionine supplementation, and limited glucose concentrations, to provide maximal conversion of the carbon source to vanillin.
  • a fed-batch fermentor is used to convert the carbon source to vanillic acid, followed by organic extraction of vanillic acid, e.g., acidification of the fermentation broth and extraction with organic solvent.
  • the fed-batch fermentor process and organic extraction methods are also known to those skilled in the art.
  • carbon source is meant to include biomass derived carbon sources including, but not limited to, xylose, arabinose, glucose and the intermediates (e.g., dicarboxylic acids) in the Krebs cycle, either alone or in combination.
  • the carbon source is glucose.
  • the recombinant microbe E. coli is employed in the methods of the present invention.
  • the E. coli comprises a mutated aroE locus and an aroB/aroZ cassette inserted into the serA locus.
  • This recombinant E. coli designated KL7, may further comprise a plasmid carrying an aroF FBR insert, a serA insert and a P tac COMT loci.
  • the lack of aroE-encoded shikimate dehydrogenase results in synthesis of 3-dehydroshikimic acid. It will be appreciated, however, that the aroE locus mutation is not essential and is employed to ensure sufficient 3-dehydroshikimic acid formation.
  • the 3-dehydroshikimic acid is converted into protocatechuic acid by genome-localized, aroZ-encoded 3-dehydroshikimate dehydratase.
  • Plasmid-localized P tac COMT encodes catechol-O-methyltransferase for conversion of protocatechuic acid into vanillic acid.
  • the two copies of aroB increase 3-dehydroquinate synthase activity to the point where the enzyme no longer impedes carbon flow. Snell, K. et al., J. Am. Chem. Soc . 118:5605 (1996).
  • the recombinant E. coil comprises plasmid pKL5.97A carrying an aroF FBR insert, a serA insert and two P tac COMT loci.
  • the aroF FBR insert encodes a 3-deoxy- D -arabino-heptulosonic acid 7-phosphate synthase isozyme insensitive to feedback inhibition which increases carbon flow into the common pathway. Due to a mutation in the E. coli genomic serA locus required for L -serine biosynthesis, growth in minimal salts medium and plasmid maintenance follows from expression of plasmid-localized serA.
  • the serA insert thus allows microbial growth in minimal salts medium, distinguishing the microbes containing the plasmid from non-plasmid containing microbes.
  • the recombinant E. coli comprises plasmid pKL5.96A which is identical to plasmid pKL5.97A except for a single P tac COMT locus as compared to the double P tac COMT loci in pKL5.97A.
  • the above-described preferred recombinant microbe of the present invention E. coli KL7/pKL5.97A
  • ATCC American Type Culture Collection
  • 1080 University Boulevard, Manassas, Va. 20110-2209 under the terms of the Budapest Treaty, and has been accorded the ATCC designation number 98859.
  • the deposit will be maintained in the ATCC depository, which is a public depository, for a period of 30 years, or 5 years after the most recent request, or for the effective life of a patent, whichever is longer, and will be replaced if the deposit becomes depleted or nonviable during that period. Samples of the deposit will become available to the public and all restrictions imposed on access to the deposit will be removed upon grant of a patent on this application.
  • the following table sets forth the five enzymes required for the conversion of glucose to vanillic acid, the genes encoding same and the origin of the genes in the exemplary recombinant microbes of the present invention.
  • E. coli is specifically described herein as the microbe for carrying out the methods of the present invention, it will be appreciated that any microorganism such as the common types cited in the literature and known to those skilled in the art, may be employed, provided the microorganism can be altered to effect the desired conversion (e.g., carbon source to vanillic acid, carbon source to 3-dehydroshikimic acid, carbon source to protocatechuic acid, vanillic acid to vanillin, 3-dehydroshikimic acid to vanillin, protocatechuic acid to vanillin, etc.)
  • fungi, bacteria and yeasts will work in the methods of the present invention.
  • Such microorganisms may be developed, for example, through selection, mutation, and/or genetic transformation processes with the characteristic and necessary capability of converting one constituent of the synthesis scheme of the present invention to another. Methods for such development are well known to the skilled practitioner.
  • a solution containing a carbon source is contacted with the recombinant microbe to form a bioconversion mixture which is maintained under appropriate conditions to promote the conversion of the carbon source to the desired constituent, e.g., vanillic acid.
  • the bioconversion mixture is maintained at a temperature of about 30° C. to about 37° C. and a pH of about 6.5 to about 7.5. It is preferred that the bioconversion mixture also contain other substances necessary to promote the viability of the recombinant microbes such as mineral salts, buffers, cofactors, nutrient substances and the like. Methionine (L, D and L-D mixtures) may also be added to the bioconversion mixture.
  • the bioconversion mixture is preferably maintained in a steady state of dissolved oxygen concentration and thus is kept under glucose limited conditions, wherein the rate of glucose addition is determined by the level of dissolved oxygen concentration.
  • a preferred steady state over the course of fermentation is about 100 to about 200 ⁇ mol glucose or a dissolved oxygen concentration of about 5% to about 35% air saturation.
  • the more general requirements for the maintenance of viability of microorganisms are well known and specific requirements for maintaining the viability of specific microorganisms are also well known as documented in the literature, or are otherwise easily determined by those skilled in the art.
  • the vanillic acid may then be recovered from the bioconversion mixture by methods known in the art (e.g., organic extraction), and contacted with aryl-aldehyde dehydrogenase to produce vanillin.
  • KL7/pKL5.26A and KL7/pKL5.97A were cultured for 48 h under fed-batch fermentor conditions at 37° C., pH 7.0, and dissolved oxygen at 20% of saturation.
  • Extracellular accumulation (FIG. 3) of vanillic, isovanillic, protocatechuic, and 3-dehydroshikimic acids began in mid log phase of microbial growth.
  • 3-Dehydroshikimic acid usually constituted 5-10 mol % of the total product mixture indicating that the rates for its biosynthesis and dehydration were nearly equal.
  • the molar dominance of protocatechuic acid (FIG. 3, Table 2) relative to vanillic acid pointed to inadequate catechol-O-methyltransferase activity.
  • Aryl-aldehyde dehydrogenase (Gross, G. G. et al., Biochem. Biophy. Res. Commun . 32:173 (1968); Gross, G. G. et al., Eur. J. Biochem . 8:413 (1969); Gross, G. G., Eur. J. Biochem . 31:585 (1972); Zenk, M. H. et al., Recent Adv. Phytochem . 4:87 (1972)) in Neurospora crassa mycelial extract was purified away from an unwanted dehydrogenase which reduced vanillin to vanillyl alcohol.
  • Vanillic, protocatechuic, and isovanillic acids were extracted into EtOAc after acidification of fermentor broth.
  • a subsequent reprecipitation step increased the vanillic acid/protocatechuic acid ratio from 1:2 to 2.5:1 (mol/mol).
  • the resulting aromatic mixture was incubated with glucose 6-phosphate dehydrogenase (to recycle NADP + ) 25 and aryl-aldehyde dehydrogenase at 30° C. and pH 8.0 using 0.07 equiv of NADP + and 2 equiv of ATP relative to vanillic acid.
  • Reduction of vanillic acid to vanillin proceeded in 92% yield in 7 h.
  • HPLC analyses employed a Rainin instrument, isocratic elution (17:2:1 H 2 O/CH 3 CN/CH 3 CO 2 H v/v), a C18 column (5 ⁇ m, Rainin Microsorb-MVTM, 4.6 ⁇ 250 mm), and detection measured at 250 nm. Samples were quantitated by comparison of the peak area of each component with a standard curve. Protein concentrations were determined using the Bradford dye-binding procedure (Bradford, M. M., Anal. Biochem . 72:248 (1976)) by comparison with a standard curve prepared from bovine serum albumin. Protein assay solution was purchased from Bio-Rad.
  • the first solution (4 mL) contained sodium phosphate (125 mM) pH 7.4, MgCl 2 (6.25 mM), S-adenosyl- L -methionine (0.75 mM), and protocatechuic acid (0.5 mM).
  • Precipitated protein was removed by centrifugation using a Beckman microfuge and components in the resulting supernatant quantitated by HPLC.
  • One unit of catechol-O-methyltransferase activity was defined as the formation of 1 ⁇ mol of vanillic acid and isovanillic acid per min at 37° C.
  • Aryl-aldehyde dehydrogenase assay solution (1 mL) containing Tris-HCl (100 mM) pH 8.0, MgCl 2 (10 mM), dithiothreitol (20 mM), NADPH (0.15 mM), ATP (20 mM), and benzoic acid (4 mM) was incubated at 30° C.
  • benzoic acid reduction was monitored at 340 nm using a Hewlett Packard 8452A UV-Vis spectrophotometer.
  • One unit of activity is defined as the loss of 1 ⁇ mol of NADPH per min at 30° C.
  • Buffers included buffer A, Tris-HCl (100 mM) and L -cysteine (10 mM), pH 7.6; buffer B, Tris-HCl (50 mM), EDTA (1 mM), DTT (1 mM), and PMSF (0.4 mM), pH 7.6; buffer C, Tris-HCl (50 mM), EDTA (1 mM), DTT (1 mM), PMSF (0.4 mM), and KCl (400 mM), pH 7.6; buffer D, Tris-HCl (20 mM), EDTA (0.4 mM), DTT (0.4 mM), and PMSF (0.15 mM), pH 7.5; and buffer E, Tris-HCl (20 mM), EDTA (0.4 mM), DTT (
  • the solid growth medium (1 L) contained sucrose (20 g), sodium citrate dihydrate (2.5 g), KH 2 PO 4 (5.0 g), NH 4 NO 3 (2.0 g), CaCl 2 ⁇ 2H 2 O (0.1 g), MgSO 4 (0.1 g), biotin (5.0 ⁇ g), and trace elements including citric acid monohydrate (5.0 mg), ZnSO 4 ⁇ 7H 2 O (5.0 mg), Fe(NH 4 ) 2 (SO 4 ) 2 ⁇ 6H 2 O (1.0 mg), CuSO 4 ⁇ 5H 2 O (0.25 mg), MnSO 4 ⁇ H 2 O (0.05 mg), H 3 BO 3 (0.05 mg), Na 2 MoO 4 ⁇ 2H 2 O (0.05 mg).
  • Difco agar was added to the medium solution at a concentration of 2% (w/v).
  • the liquid growth medium differed from solid growth medium only in the addition of Difco yeast extract (2.0 g/L) and sodium salicylate (1.6 g/L).
  • N. crassa SY 7A was grown on solid growth medium at 24° C. for 7 days and a mixture of mycelium and spores was obtained. After suspension in sterilized water, the mixture of mycelium and spores was filtered through sterilized glass wool. The resulting spore suspension was stored at 4° C. Fresh spores stored at 4° C.
  • the column was washed with 500 mL of buffer B followed by elution with a linear gradient (1.5 L+1.5 L, buffer B-buffer C). Fractions containing aryl-aldehyde dehydrogenase were combined and concentrated to 30 mL. After dialysis against buffer D (3 ⁇ ), The protein was loaded on a RedA column (2.5 ⁇ 8 cm) equilibrated with buffer D. The column was washed with 200 mL buffer D and eluted with a linear gradient (150 mL+150 mL, buffer D/buffer E). Active fractions were concentrated, quick frozen in liquid nitrogen, and stored at ⁇ 80° C.
  • Fermentations employed a 2.0 L capacity Biostat MD B-Braun fermentor connected to a DCU system and a Compaq computer equipped with B-Braun MFCS software for data acquisition and automatic process monitoring.
  • the temperature, pH and glucose feeding were controlled with a PID controller.
  • the temperature was maintained at 37° C. pH was maintained at 7.0 by addition of concentrated NH 4 OH or 2 N H 2 SO 4 .
  • Dissolved oxygen (D.O.) was measured using a Braun polarographic probe. D.O. was maintained at 20% air saturation over the entire course of the fermentation.
  • Antifoam (Sigma 204) was added manually as needed.
  • LB medium contained Bacto tryptone (10 g), Bacto yeast extract (5 g), and NaCl (10 g).
  • Fermentation medium (1 L) contained K 2 HPO 4 (7.5 g), ammonium iron(III) citrate (0.3 g), citric acid monohydrate (2.1 g), and concentrated H 2 SO 4 (1.2 mL). The culture medium was adjusted to pH 7 by addition of concentrated NH 4 OH before autoclaving.
  • D -Glucose, MgSO 4 , and aromatic amino acids were autoclaved while aromatic vitamins and trace minerals were sterilized through 0.22 ⁇ m membranes prior to addition to the medium.
  • Antibiotics were added where appropriate to the following final concentrations: chloramphenicol (Cm), 20 ⁇ g/mL; ampicillin (Ap), 50 ⁇ g/mL.
  • Solid medium was prepared by addition of 1.5% (w/v) Difco agar to medium solution.
  • Inoculants were grown in 100 mL LB medium (enriched with 2 g glucose) containing the appropriate antibiotic for 12 h at 37° C. with agitation at 250 rpm and then transferred to the fermentor.
  • the initial glucose concentration in the fermentation medium was 20 g/L.
  • L -Methionine supplementation when employed, consisted of addition of a filter-sterilized solution containing 0.4 g of this amino acid in timed intervals (6 h) starting at 12 h after initiation of a fermentor run.
  • Three different methods were used to maintain dissolved oxygen (D.O.) levels at 20% air saturation during each 48 h fermentor run. The dissolved oxygen concentration was first maintained by increasing the impeller speed.
  • the mass flow controller then maintained D.O. levels at 20% saturation at constant impeller speed by increasing the airflow rate over approximately 2 h from 0.06 L/L/min to a preset maximum of 1.0 L/L/min.
  • D.O. levels were maintained at 20% saturation for the remainder of the fermentation by oxygen sensor-controlled glucose feeding.
  • dissolved oxygen levels fell below 20% saturation due to residual initial glucose in the medium. This lasted for approximately 1 h before glucose (60% w/v) feeding started.
  • the PID control parameters were set to 0.0 (off for the derivative control ( T D ), 999.9 s (minimum control action) for the integral control ( T l ), and 950.0% for the proportional band (X p ).
  • catechol-O-methyltransferase activity is the average of 12 h and 36 h specific activities. After 48 h, cells were removed by centrifugation at 16000 g for 10 min and the supernatant stored at 4° C.
  • the collected precipitate was dissolved in a solution (100 mL) containing Tris-HCl (200 mM), pH 8.0, MgCl 2 (100 mM), DTT (10 mM), ATP (60 mM), NADP + (2 mM), glucose 6-phosphate (60 mM), 2,000 units of glucose 6-phosphate dehydrogenase and 200 unit of the partially purified aryl-aldehyde dehydrogenase. Reduction proceeded at 30° C. and was monitored by HPLC. After 7 h reaction, 92% (mol/mol) of the starting vanillic acid and 34% (mol/mol) of the protocatechuic acid had been reduced. The reaction mixture was extracted with 100 mL CH 2 Cl 2 (3 ⁇ ). The combined organic extracts were washed one time with equal volume of water. Concentration afforded a powder consisting of (FIG. 4) vanillin (0.30 g) and isovanillin (0.03 g).
  • vanillate-synthesizing microbe designed with a protocatechuic acid uptake system so that protocatechuic acid escaping into the culture supernatant can be transported back into the cytoplasm for methylation, would also be desirable.
  • Biocatalytic synthesis of vanillin from a carbon source such as glucose has a number of advantages relative to other biocatalytic vanillin syntheses.
  • Coniferol formed during phenylpropanoid biosynthesis, is converted into coniferin by a glucosyltransferase in Vanilla planifolia .
  • Coniferin is then transformed into glucovanillin which is finally hydrolyzed by a ⁇ -glucosidase.
  • Ranadive A.
  • Corrosive H 2 O 2 used for oxidation of phenol into catechol requires special handling precautions (Campbell, C. J. et al., Sci. Am . 278(3):78 (1998)) while biocatalytically synthesized vanillin derives its oxygen atoms from the oxygen atoms of glucose.
  • Dimethyl sulfate, a carcinogen, (Campbell, C. J. et al., Sci. Am . 278(3):78 (1998)) has historically been used to methylate catechol.
  • Protocatechuic acid methylation employs S-adenosylmethionine generated and consumed intracellularly.
  • synthetic vanillin manufacture is based on use of nonrenewable petroleum whereas glucose is derived from abundant, renewable starch. This difference in feedstock utilization is important given projected fierce international competition as global petroleum production diminishes. Campbell, C. J. et al., Sci. Am . 278(3):78 (1998).

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
US09/397,720 1998-09-18 1999-09-16 Synthesis of vanillin from a carbon source Expired - Lifetime US6372461B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/397,720 US6372461B1 (en) 1998-09-18 1999-09-16 Synthesis of vanillin from a carbon source

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10093798P 1998-09-18 1998-09-18
US09/397,720 US6372461B1 (en) 1998-09-18 1999-09-16 Synthesis of vanillin from a carbon source

Publications (1)

Publication Number Publication Date
US6372461B1 true US6372461B1 (en) 2002-04-16

Family

ID=22282303

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/397,720 Expired - Lifetime US6372461B1 (en) 1998-09-18 1999-09-16 Synthesis of vanillin from a carbon source

Country Status (6)

Country Link
US (1) US6372461B1 (de)
EP (1) EP1114173A4 (de)
KR (1) KR20010085827A (de)
AU (1) AU6043399A (de)
CA (1) CA2344665A1 (de)
WO (1) WO2000017319A2 (de)

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030138810A1 (en) * 2000-10-13 2003-07-24 Farnet Chris M. High throughput method for discovery of gene clusters
EP1510586A1 (de) * 2003-08-26 2005-03-02 Poalis A/S Verfahren zur Herstellung einer organischen Verbindung mit niederem Molekulargewicht in einer Zelle
US20060275877A1 (en) * 2003-06-19 2006-12-07 Joergen Hansen Method of producing a low molecular weight organic compound in a cell
US20070270620A1 (en) * 2006-02-13 2007-11-22 Council Of Scientific And Industrial Research Process for the preparation of vanillin from agricultural waste
WO2008130210A1 (es) 2007-04-19 2008-10-30 Biokab, S.A. De C. V. Proceso para producir vainillina a partir de microorganismos inmovilizados por cultivo de superficie
US20100285105A1 (en) * 2006-08-01 2010-11-11 Helia Radianingtyas Oil producing microbes adn method of modification thereof
WO2013022881A1 (en) * 2011-08-08 2013-02-14 International Flavors & Fragrances Inc. Compositions and methods for the biosynthesis of vanillin or vanillin beta-d-glucoside
EP2749644A1 (de) 2012-12-27 2014-07-02 Eviagenics S.A. Rekombinante Wirtszelle zur biosynthetischen Herstellung von Vanillin
US8921069B2 (en) 2005-06-07 2014-12-30 Dsm Nutritional Products Ag Eukaryotic microorganisms for producing lipids and antioxidants
WO2015009558A1 (en) * 2013-07-16 2015-01-22 International Flavors & Fragrances Inc. Compositions and methods for the biosynthesis of vanillin or vanillin beta-d-glucoside
US20150252397A1 (en) * 2012-08-28 2015-09-10 Privi Biotechnologies Private Limited Continuous biotransformation of substituted aromatic carboxylic acids to their selective aldehydes and alcohols
WO2016005998A1 (en) 2014-07-08 2016-01-14 Council Of Scientific & Industrial Research A method for the isolation of vanillin from rice straw
US9873880B2 (en) 2013-03-13 2018-01-23 Dsm Nutritional Products Ag Engineering microorganisms
WO2018079683A1 (en) 2016-10-26 2018-05-03 Ajinomoto Co., Inc. Method for producing objective substance
WO2018079705A1 (en) 2016-10-27 2018-05-03 Ajinomoto Co., Inc. Method for producing aldehyde
WO2018079684A1 (en) 2016-10-26 2018-05-03 Ajinomoto Co., Inc. Method for producing objective substance
WO2018079685A1 (en) 2016-10-26 2018-05-03 Ajinomoto Co., Inc. Method for producing objective substance
WO2018079686A1 (en) 2016-10-26 2018-05-03 Ajinomoto Co., Inc. Method for producing l-methionine or metabolites requiring s-adenosylmethionine for synthesis
WO2018079687A1 (en) 2016-10-26 2018-05-03 Ajinomoto Co., Inc. Method for producing objective substance
EP3406727A1 (de) 2017-05-22 2018-11-28 Ajinomoto Co., Inc. Verfahren zur herstellung einer zielsubstanz
EP3502263A2 (de) 2017-11-29 2019-06-26 Ajinomoto Co., Inc. Verfahren zur herstellung einer zielsubstanz
US10519472B2 (en) 2012-12-27 2019-12-31 Rhodia Operations Recombinant host cell for biosynthetic production
WO2020027251A1 (en) 2018-08-03 2020-02-06 Ajinomoto Co., Inc. Method for producing objective substance
WO2021022216A1 (en) 2019-08-01 2021-02-04 Amyris, Inc. Modified host cells for high efficiency production of vanillin
WO2022060867A1 (en) 2020-09-15 2022-03-24 Amyris, Inc. Culture compositions and methods of their use for high yield production of vanillin
WO2022198088A1 (en) 2021-03-19 2022-09-22 Amyris, Inc. Modified host cells for high efficiency production of vanillin

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5279950A (en) 1991-05-31 1994-01-18 Kraft General Foods, Inc. Bioconversion process for the production of vanillin
US5629181A (en) * 1993-09-16 1997-05-13 Purdue Research Foundation Synthesis of catechol from biomass-derived carbon sources
US5795759A (en) * 1997-03-10 1998-08-18 The University Of Iowa Research Foundation Carboxylic acid reductase, and methods of using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3920039A1 (de) * 1989-06-20 1991-01-03 Haarmann & Reimer Gmbh Verfahren zur herstellung von natuerlichem vanillin
US5262315A (en) * 1990-04-19 1993-11-16 Pernod Ricard Production of vanillin by bioconversion of benzenoid precursors by pyenoporus
US5776736A (en) * 1992-12-21 1998-07-07 Purdue Research Foundation Deblocking the common pathway of aromatic amino acid synthesis
KR100493538B1 (ko) * 1997-02-07 2005-08-04 교와 핫꼬 고교 가부시끼가이샤 페르라산탈탄산효소

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5279950A (en) 1991-05-31 1994-01-18 Kraft General Foods, Inc. Bioconversion process for the production of vanillin
US5629181A (en) * 1993-09-16 1997-05-13 Purdue Research Foundation Synthesis of catechol from biomass-derived carbon sources
US5795759A (en) * 1997-03-10 1998-08-18 The University Of Iowa Research Foundation Carboxylic acid reductase, and methods of using same

Non-Patent Citations (18)

* Cited by examiner, † Cited by third party
Title
Campbell, C.J. et al., "The End of Cheap Oil," Sci. Am. 278(3):77-83 (1998).
Clark, G.S., "Vanillin," Perfum. Flavor. 15:45-54 (1990).
Coward, J.K. et al., "Kinetic Studies on Catechol O-Methyltransferase. Product Inhibition and the Nature of the Catechol Binding Site," Biochemistry 12(12):2291-2297 (1973).
Esposito, L. et al., "Vanillin," Kirk-Othmer Encyclopedia of Chemical Technology, Fourth Ed., Kroschwitz, J.I., Howe-Grant, M., Ed., Wiley: New York, vol. 24:812-925 (1997).
Falconnier, B. et al., "Vanillin as a product of ferulic acid biotransformation by the white-rot fungus Pycnoporus cinabarinus I-937: Identification of metabolic pathways," J. Biotechnol. 37:123-132 (1994).
Gross, G.G. et al., "Reduction of Cinnamic Acid to Cinnamaldehyde and Alcohol," Biochem. Biophy. Res. Commun. 32(2):173-178 (1968).
Gross, G.G. et al., "Reduktion aromatischer Sauren zu Aldehyden und Alkoholen im zellfreien System," Eur. J. Biochem. 8:413-419 (1969).
Gross, G.G., "Formation and Reduction of Intermediate Acyladenylate by Acryl-Aldehyde," Eur. J. Biochem. 31:585-592 (1972).
Guldberg, H.A. et al., "Catechol-O-Methyl Transferase: Pharmacological Aspects and Physiological Role," Pharmacological Reviews 27(2):135-206 (1975).
Lesage-Meessen, L. et al., "A two-step bioconversion process for vanillin production from ferulic acid combining Aspergillus niger and Pycnoporus cinnabarinus," J. Biotechnol. 50:107-113 (1996).
Lesage-Meessen, L. et al., "An attemp to channel the transformation of vanillic acid into vanillin by controlling methoxyhydroquinone formation in Pycnoporus cinnabarinus with cellobiose," Appl. Microbiol. Biotechnol. 47:393-397 (1997).
Ranadive, A.S., "Vanilla-Cultivation, Curing, Chemistry, Technology and Commercial Products," In Spices, Herbs, and Edible Fungi, Charalambous, G., Ed., Elsevier: Amsterdam, pp. 517-577 (1994).
Reenila, I. et al., "Opposite Effect of Ethanol on Recombinant Membrane-Bound and Soluble Activities of Catechol-O-methyltransferase," Pharmacology & Toxicology 77:414-416 (1995).
Snell, K. et al., "Synthetic Modification of the Escherichia coli Chromosome: Enhancing the Biocatalytic Conversion of Glucose into Aromatic Chemicals," J. Am. Chem. Soc. 118(24):5605-5614 (1996).
Tuomainen et al. "Validation of assay of catechol-O-methyltransferase activity in human erythrocytes", (1996), J Pharm Biomed Anal 14:515-523.* *
Weaver et al. "Cloning of an aroF allele encoding a tyrosine insensitive 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase", (1990) J Bacteriol 172:6581-6584.* *
Westcott, R.J. et al., "Use of Organized Viable Vanilla Plant Aerial Roots for the Production of Natural Vanillin," Phytochemistry 35(1):135-138 (1994).
Zenk, M.H. et al., "The Enzymic Reduction of Cinnamic Acids," Recent Adv. Phytochem. 4:87-106 (1972).

Cited By (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030138810A1 (en) * 2000-10-13 2003-07-24 Farnet Chris M. High throughput method for discovery of gene clusters
EP2388333A2 (de) 2003-06-19 2011-11-23 Evolva SA Verfahren zur Herstellung einer organischen Verbindung mit geringem Molekulargewicht in einer Zelle
US20060275877A1 (en) * 2003-06-19 2006-12-07 Joergen Hansen Method of producing a low molecular weight organic compound in a cell
US8986950B2 (en) * 2003-06-19 2015-03-24 Evolva Sa Method of producing a low molecular weight organic compound in a cell
US8105786B2 (en) 2003-06-19 2012-01-31 Evolva Sa Method of producing a low molecular weight organic compound in a cell
US20110318793A1 (en) * 2003-06-19 2011-12-29 Evolva Sa Method of Producing a Low Molecular Weight Organic Compound in a Cell
US7846697B2 (en) 2003-06-19 2010-12-07 BLMaps Method of producing a low molecular weight organic compound in a cell
US20110136177A1 (en) * 2003-06-19 2011-06-09 BLMaps Method of Producing a Low Molecular Weight Organic Compound in a Cell
EP1510586A1 (de) * 2003-08-26 2005-03-02 Poalis A/S Verfahren zur Herstellung einer organischen Verbindung mit niederem Molekulargewicht in einer Zelle
US10435725B2 (en) 2005-06-07 2019-10-08 Dsm Nutritional Products Ag Eukaryotic microorganisms for producing lipids and antioxidants
US8921069B2 (en) 2005-06-07 2014-12-30 Dsm Nutritional Products Ag Eukaryotic microorganisms for producing lipids and antioxidants
US9719116B2 (en) 2005-06-07 2017-08-01 Dsm Nutritional Prodcuts Ag Eukaryotic microorganisms for producing lipids and antioxidants
US7399889B2 (en) * 2006-02-13 2008-07-15 Council Of Scientific And Industrial Research Process for the preparation of vanillin from agricultural waste
US20070270620A1 (en) * 2006-02-13 2007-11-22 Council Of Scientific And Industrial Research Process for the preparation of vanillin from agricultural waste
US20100285105A1 (en) * 2006-08-01 2010-11-11 Helia Radianingtyas Oil producing microbes adn method of modification thereof
US9023616B2 (en) 2006-08-01 2015-05-05 Dsm Nutritional Products Ag Oil producing microbes and method of modification thereof
WO2008130210A1 (es) 2007-04-19 2008-10-30 Biokab, S.A. De C. V. Proceso para producir vainillina a partir de microorganismos inmovilizados por cultivo de superficie
CN105063104B (zh) * 2011-08-08 2019-08-13 国际香料香精公司 用于香草醛或香草醛β-D-葡萄糖苷的生物合成的组合物和方法
CN108570464B (zh) * 2011-08-08 2021-12-21 国际香料香精公司 用于香草醛或香草醛β-D-葡萄糖苷的生物合成的组合物和方法
US20140245496A1 (en) * 2011-08-08 2014-08-28 Evolva Sa Compositions and methods for the biosynthesis of vanillan or vanillin beta-d-glucoside
EP2742126A4 (de) * 2011-08-08 2015-04-22 Int Flavors & Fragrances Inc Zusammensetzungen und verfahren für die biosynthese von vanillin oder vanillin-beta-d-glucosid
CN103987840A (zh) * 2011-08-08 2014-08-13 国际香料香精公司 用于香草醛或香草醛β-D-葡萄糖苷的生物合成的组合物和方法
CN108570464A (zh) * 2011-08-08 2018-09-25 国际香料香精公司 用于香草醛或香草醛β-D-葡萄糖苷的生物合成的组合物和方法
CN105063104A (zh) * 2011-08-08 2015-11-18 国际香料香精公司 用于香草醛或香草醛β-D-葡萄糖苷的生物合成的组合物和方法
US10208293B2 (en) * 2011-08-08 2019-02-19 International Flavors & Fragrances Inc. Compositions and methods for the biosynthesis of vanillan or vanillin beta-D-glucoside
EP3118304A1 (de) 2011-08-08 2017-01-18 International Flavors & Fragrances Inc. Zusammensetzungen und verfahren für die biosynthese von vanillin oder vanillin-beta-d-glucosid
WO2013022881A1 (en) * 2011-08-08 2013-02-14 International Flavors & Fragrances Inc. Compositions and methods for the biosynthesis of vanillin or vanillin beta-d-glucoside
EP2742126A1 (de) * 2011-08-08 2014-06-18 International Flavors & Fragrances Inc. Zusammensetzungen und verfahren für die biosynthese von vanillin oder vanillin-beta-d-glucosid
EP3514226A1 (de) 2011-08-08 2019-07-24 International Flavors & Fragrances Inc. Zusammensetzungen und verfahren für die biosynthese von vanillin oder vanillin-beta-d-glucosid
US10017797B2 (en) * 2012-08-28 2018-07-10 Privi Biotechnologies Private Limited Continuous biotransformation of substituted aromatic carboxylic acids to their selective aldehydes and alcohols
US20150252397A1 (en) * 2012-08-28 2015-09-10 Privi Biotechnologies Private Limited Continuous biotransformation of substituted aromatic carboxylic acids to their selective aldehydes and alcohols
US10519472B2 (en) 2012-12-27 2019-12-31 Rhodia Operations Recombinant host cell for biosynthetic production
EP2749644B1 (de) 2012-12-27 2018-08-22 Rhodia Operations Rekombinante Wirtszelle zur biosynthetischen Herstellung von Vanillin
EP2749644A1 (de) 2012-12-27 2014-07-02 Eviagenics S.A. Rekombinante Wirtszelle zur biosynthetischen Herstellung von Vanillin
US9873880B2 (en) 2013-03-13 2018-01-23 Dsm Nutritional Products Ag Engineering microorganisms
US10000782B2 (en) 2013-07-16 2018-06-19 International Flavors & Fragrances Inc. Recombinant host cell for the biosynthesis of vanillin or vanillin beta-D-glucoside
WO2015009558A1 (en) * 2013-07-16 2015-01-22 International Flavors & Fragrances Inc. Compositions and methods for the biosynthesis of vanillin or vanillin beta-d-glucoside
US10066252B1 (en) 2013-07-16 2018-09-04 International Flavors & Fragrances Inc. Compositions and methods for the biosynthesis of vanillin or vanillin beta-D glucoside
WO2016005998A1 (en) 2014-07-08 2016-01-14 Council Of Scientific & Industrial Research A method for the isolation of vanillin from rice straw
WO2018079684A1 (en) 2016-10-26 2018-05-03 Ajinomoto Co., Inc. Method for producing objective substance
US10876138B2 (en) 2016-10-26 2020-12-29 Ajinomoto Co., Inc. Method for producing objective substance
WO2018079687A1 (en) 2016-10-26 2018-05-03 Ajinomoto Co., Inc. Method for producing objective substance
WO2018079683A1 (en) 2016-10-26 2018-05-03 Ajinomoto Co., Inc. Method for producing objective substance
US11053519B2 (en) 2016-10-26 2021-07-06 Ajinomoto Co., Inc. Method for producing objective substance
WO2018079686A1 (en) 2016-10-26 2018-05-03 Ajinomoto Co., Inc. Method for producing l-methionine or metabolites requiring s-adenosylmethionine for synthesis
WO2018079685A1 (en) 2016-10-26 2018-05-03 Ajinomoto Co., Inc. Method for producing objective substance
US10883124B2 (en) 2016-10-26 2021-01-05 Ajinomoto Co., Inc. Method for producing objective substance
WO2018079705A1 (en) 2016-10-27 2018-05-03 Ajinomoto Co., Inc. Method for producing aldehyde
US10883125B2 (en) 2016-10-27 2021-01-05 Ajinomoto Co., Inc. Method for producing aldehyde
US10858676B2 (en) 2017-05-22 2020-12-08 Ajinomoto Co., Inc. Method for producing objective substance
EP3406727A1 (de) 2017-05-22 2018-11-28 Ajinomoto Co., Inc. Verfahren zur herstellung einer zielsubstanz
EP3502263A2 (de) 2017-11-29 2019-06-26 Ajinomoto Co., Inc. Verfahren zur herstellung einer zielsubstanz
US11680279B2 (en) 2017-11-29 2023-06-20 Ajinomoto Co., Inc. Method for producing objective substance
WO2020027251A1 (en) 2018-08-03 2020-02-06 Ajinomoto Co., Inc. Method for producing objective substance
WO2021022216A1 (en) 2019-08-01 2021-02-04 Amyris, Inc. Modified host cells for high efficiency production of vanillin
WO2022060867A1 (en) 2020-09-15 2022-03-24 Amyris, Inc. Culture compositions and methods of their use for high yield production of vanillin
WO2022198088A1 (en) 2021-03-19 2022-09-22 Amyris, Inc. Modified host cells for high efficiency production of vanillin

Also Published As

Publication number Publication date
CA2344665A1 (en) 2000-03-30
EP1114173A2 (de) 2001-07-11
EP1114173A4 (de) 2005-02-16
AU6043399A (en) 2000-04-10
KR20010085827A (ko) 2001-09-07
WO2000017319A2 (en) 2000-03-30
WO2000017319A3 (en) 2000-07-27

Similar Documents

Publication Publication Date Title
US6372461B1 (en) Synthesis of vanillin from a carbon source
Carroll et al. Microbial production of scent and flavor compounds
US7642083B2 (en) Biocatalytic synthesis of quinic acid and conversion to hydroquinone by recombinant microbes
Li et al. Fed‐batch fermentor synthesis of 3‐dehydroshikimic acid using recombinant Escherichia coli
Hansen et al. De novo biosynthesis of vanillin in fission yeast (Schizosaccharomyces pombe) and baker's yeast (Saccharomyces cerevisiae)
EP2046966B1 (de) Stoffwechseltechnisch manipulierte zellen zur herstellung von pinosylvin
US6613552B1 (en) Biocatalytic synthesis of shikimic acid
Steinbüchel et al. Excretion of pyruvate by mutants of Alcaligenes eutrophus, which are impaired in the accumulation of poly (β-hydroxybutyric acid)(PHB), under conditions permitting synthesis of PHB
KR101814888B1 (ko) 5-아미노레불린산 고수율 균주 및 이의 제조방법과 응용
US9663768B2 (en) Precursor-directed biosynthesis of 5-hydroxytryptophan
WO2018069418A2 (en) Production of citronellal and citronellol in recombinant hosts
CN109295113A (zh) 一种生产羟基酪醇的方法
JPH09506242A (ja) バイオマス由来炭素源からカテコールを合成する方法
US20040209337A1 (en) Synthesis of 1,2,3,4-tetrahydroxybenzenes from biomass-derived carbon
US6472190B1 (en) Biocatalytic synthesis of galloid organics
CN109370967A (zh) 一种工程菌及其在酪醇生产中的应用
US5798236A (en) Synthesis of quinic acid from glucose
CA2328598A1 (en) Microbial preparation of substances from aromatic metabolism/iii
Furukawa et al. Conversion of isoeugenol into vanillic acid byPseudomonas putida I58 cells exhibiting high isoeugenol-degrading activity
Malaoui et al. Influence of glucose on glycerol metabolism by wild-type and mutant strains of Clostridium butyricum E5 grown in chemostat culture
BRPI0414673B1 (pt) escherichia coli recombinante, bem como método para a produção de ácido d-láctico
KR20150006412A (ko) 미생물에 의한 ｎ-부티르알데하이드의 생성
US20140024092A1 (en) Modified 13-hydroperoxide lyases and uses thereof
US20080176300A1 (en) Microbial conversion of sugar acids and means therein
Schneider et al. A Fatty Acid α-Ketol, a Product of the Plant Lipoxygenase Pathway, Is Oxidized to 3 (Z)-Dodecendioic Acid by a Bacterial Monooxygenase

Legal Events

Date Code Title Description
AS Assignment

Owner name: BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FROST, JOHN W.;REEL/FRAME:010420/0984

Effective date: 19991109

STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
FEPP Fee payment procedure

Free format text: PAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

REFU Refund

Free format text: REFUND - SURCHARGE, PETITION TO ACCEPT PYMT AFTER EXP, UNINTENTIONAL (ORIGINAL EVENT CODE: R2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FEPP Fee payment procedure

Free format text: PAT HOLDER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: LTOS); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FPAY Fee payment

Year of fee payment: 12

SULP Surcharge for late payment

Year of fee payment: 11

CC Certificate of correction
AS Assignment

Owner name: NATIONAL SCIENCE FOUNDATION, VIRGINIA

Free format text: CONFIRMATORY LICENSE;ASSIGNOR:MICHIGAN STATE UNIVERSITY;REEL/FRAME:033460/0604

Effective date: 20131118